X-70424991-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017711.4(GDPD2):c.7G>A(p.Glu3Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,186,936 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 31 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E3D) has been classified as Uncertain significance.
Frequency
Consequence
NM_017711.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDPD2 | ENST00000374382.4 | c.7G>A | p.Glu3Lys | missense_variant | Exon 2 of 16 | 1 | NM_017711.4 | ENSP00000363503.3 | ||
GDPD2 | ENST00000453994.6 | c.7G>A | p.Glu3Lys | missense_variant | Exon 2 of 17 | 2 | ENSP00000414019.2 | |||
GDPD2 | ENST00000536730.5 | c.-132-363G>A | intron_variant | Intron 1 of 14 | 2 | ENSP00000445982.1 | ||||
GDPD2 | ENST00000538649.5 | c.-28-772G>A | intron_variant | Intron 1 of 13 | 2 | ENSP00000444601.1 |
Frequencies
GnomAD3 genomes AF: 0.0000981 AC: 11AN: 112111Hom.: 0 Cov.: 23 AF XY: 0.000146 AC XY: 5AN XY: 34289
GnomAD3 exomes AF: 0.0000341 AC: 5AN: 146559Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 43563
GnomAD4 exome AF: 0.000105 AC: 113AN: 1074825Hom.: 0 Cov.: 28 AF XY: 0.0000749 AC XY: 26AN XY: 346913
GnomAD4 genome AF: 0.0000981 AC: 11AN: 112111Hom.: 0 Cov.: 23 AF XY: 0.000146 AC XY: 5AN XY: 34289
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.7G>A (p.E3K) alteration is located in exon 2 (coding exon 1) of the GDPD2 gene. This alteration results from a G to A substitution at nucleotide position 7, causing the glutamic acid (E) at amino acid position 3 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at